Cumberland Pharmaceuticals Inc.: accounts_receivable
| Value | {"amount": 7844249, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-12-31) |
| Status | superseded |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:03.146245+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d0ccf803-1aa0-4b24-8cb4-f774c73aa834
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-19-002785Retrieved: 2026-08-19T10:49:03.146245+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/accounts-receivable/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d0ccf803-1aa0-4b24-8cb4-f774c73aa834
History
- no predecessors — first report